Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 23 | 2023 | 80 | 6.750 |
Why?
|
| Osteoporotic Fractures | 8 | 2022 | 12 | 4.010 |
Why?
|
| Absorptiometry, Photon | 20 | 2022 | 76 | 3.190 |
Why?
|
| Bone Density | 22 | 2022 | 134 | 2.260 |
Why?
|
| Bone Density Conservation Agents | 4 | 2022 | 14 | 2.120 |
Why?
|
| Risk Assessment | 11 | 2022 | 679 | 1.530 |
Why?
|
| Femur Neck | 4 | 2017 | 18 | 1.280 |
Why?
|
| Osteoporosis, Postmenopausal | 3 | 2022 | 4 | 1.250 |
Why?
|
| Fractures, Bone | 7 | 2011 | 73 | 0.930 |
Why?
|
| Societies, Medical | 9 | 2013 | 190 | 0.820 |
Why?
|
| Diphosphonates | 3 | 2023 | 17 | 0.790 |
Why?
|
| Delivery of Health Care | 2 | 2018 | 152 | 0.720 |
Why?
|
| Risk Factors | 12 | 2023 | 2443 | 0.660 |
Why?
|
| Calcaneus | 1 | 2017 | 6 | 0.630 |
Why?
|
| Secondary Prevention | 4 | 2021 | 64 | 0.610 |
Why?
|
| Practice Guidelines as Topic | 5 | 2013 | 333 | 0.600 |
Why?
|
| Congresses as Topic | 2 | 2013 | 33 | 0.590 |
Why?
|
| Ultrasonography | 2 | 2017 | 226 | 0.560 |
Why?
|
| Humans | 35 | 2023 | 29337 | 0.540 |
Why?
|
| Hip Fractures | 4 | 2023 | 32 | 0.510 |
Why?
|
| Patient Compliance | 1 | 2014 | 164 | 0.470 |
Why?
|
| Algorithms | 5 | 2021 | 400 | 0.370 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 208 | 0.370 |
Why?
|
| Jaw Diseases | 1 | 2009 | 1 | 0.350 |
Why?
|
| Collagen Type I | 1 | 2009 | 18 | 0.350 |
Why?
|
| Osteonecrosis | 1 | 2009 | 19 | 0.350 |
Why?
|
| Peptides | 1 | 2009 | 95 | 0.330 |
Why?
|
| Densitometry | 1 | 2007 | 10 | 0.320 |
Why?
|
| Electronic Health Records | 2 | 2018 | 66 | 0.300 |
Why?
|
| Spinal Fractures | 3 | 2017 | 60 | 0.300 |
Why?
|
| Spine | 1 | 2007 | 121 | 0.280 |
Why?
|
| Accidental Falls | 2 | 2021 | 116 | 0.270 |
Why?
|
| Radiation Monitoring | 1 | 2005 | 1 | 0.260 |
Why?
|
| Safety Management | 1 | 2005 | 24 | 0.260 |
Why?
|
| Primary Prevention | 2 | 2017 | 38 | 0.250 |
Why?
|
| Lumbar Vertebrae | 2 | 2007 | 487 | 0.250 |
Why?
|
| Retrospective Studies | 4 | 2023 | 3273 | 0.240 |
Why?
|
| Female | 10 | 2022 | 16197 | 0.230 |
Why?
|
| Periprosthetic Fractures | 1 | 2023 | 32 | 0.230 |
Why?
|
| Denosumab | 1 | 2022 | 1 | 0.220 |
Why?
|
| Teriparatide | 1 | 2022 | 1 | 0.220 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2022 | 2 | 0.220 |
Why?
|
| Alendronate | 1 | 2022 | 8 | 0.220 |
Why?
|
| Middle Aged | 6 | 2022 | 9823 | 0.220 |
Why?
|
| Adult | 8 | 2022 | 8601 | 0.190 |
Why?
|
| RNA, Messenger | 5 | 1990 | 323 | 0.180 |
Why?
|
| Guidelines as Topic | 2 | 2012 | 67 | 0.180 |
Why?
|
| Child | 6 | 2009 | 1346 | 0.180 |
Why?
|
| Cytochrome c Group | 3 | 1990 | 6 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 1990 | 9 | 0.170 |
Why?
|
| Cytochromes c | 3 | 1990 | 15 | 0.170 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1990 | 18 | 0.170 |
Why?
|
| Aged | 5 | 2022 | 9448 | 0.170 |
Why?
|
| Bone and Bones | 2 | 2009 | 119 | 0.160 |
Why?
|
| Finger Phalanges | 1 | 2017 | 4 | 0.160 |
Why?
|
| Cancellous Bone | 1 | 2017 | 4 | 0.160 |
Why?
|
| Protein Biosynthesis | 3 | 1988 | 26 | 0.150 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 28 | 0.150 |
Why?
|
| Radius | 1 | 2017 | 32 | 0.150 |
Why?
|
| Male | 8 | 2018 | 15621 | 0.150 |
Why?
|
| Patient Care Team | 1 | 2018 | 140 | 0.140 |
Why?
|
| Canada | 2 | 2014 | 56 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 770 | 0.140 |
Why?
|
| United States | 1 | 2022 | 2333 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 221 | 0.130 |
Why?
|
| Hospitalization | 1 | 2018 | 317 | 0.130 |
Why?
|
| Chicago | 1 | 2018 | 865 | 0.130 |
Why?
|
| Tibia | 1 | 2017 | 259 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 959 | 0.130 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2023 | 863 | 0.130 |
Why?
|
| Repressor Proteins | 2 | 1991 | 29 | 0.120 |
Why?
|
| Forensic Anthropology | 1 | 2014 | 1 | 0.120 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 10 | 0.120 |
Why?
|
| ROC Curve | 1 | 2014 | 138 | 0.120 |
Why?
|
| Adolescent | 4 | 2022 | 2279 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2014 | 321 | 0.110 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2010 | 16 | 0.110 |
Why?
|
| Trans-Activators | 2 | 1991 | 24 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2014 | 330 | 0.110 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 1991 | 1 | 0.100 |
Why?
|
| Chimera | 1 | 1991 | 5 | 0.100 |
Why?
|
| Morbidity | 1 | 2011 | 63 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 20 | 0.100 |
Why?
|
| Recurrence | 1 | 2012 | 350 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2010 | 78 | 0.090 |
Why?
|
| World Health Organization | 1 | 2008 | 18 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2010 | 96 | 0.080 |
Why?
|
| Mutation | 3 | 1990 | 383 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2014 | 1939 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 148 | 0.080 |
Why?
|
| Pediatrics | 1 | 2008 | 33 | 0.080 |
Why?
|
| Observer Variation | 1 | 2007 | 118 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 96 | 0.080 |
Why?
|
| Software | 1 | 2007 | 72 | 0.080 |
Why?
|
| Reference Values | 1 | 2007 | 227 | 0.080 |
Why?
|
| Internet | 1 | 2007 | 91 | 0.070 |
Why?
|
| Incidence | 1 | 2008 | 756 | 0.070 |
Why?
|
| Biomarkers | 1 | 2009 | 689 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2006 | 111 | 0.060 |
Why?
|
| Age Factors | 3 | 2010 | 843 | 0.060 |
Why?
|
| Base Sequence | 5 | 1990 | 134 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 1990 | 108 | 0.050 |
Why?
|
| Amino Acid Sequence | 4 | 1990 | 193 | 0.050 |
Why?
|
| Transcription Factors | 2 | 1990 | 156 | 0.040 |
Why?
|
| Reoperation | 1 | 2023 | 932 | 0.040 |
Why?
|
| HeLa Cells | 4 | 1991 | 50 | 0.040 |
Why?
|
| Alleles | 3 | 1990 | 224 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 1990 | 246 | 0.040 |
Why?
|
| Kinetics | 2 | 1991 | 225 | 0.030 |
Why?
|
| Young Adult | 2 | 2009 | 1932 | 0.030 |
Why?
|
| Genes, Fungal | 2 | 1990 | 2 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 2 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 1991 | 13 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 38 | 0.030 |
Why?
|
| Mammals | 1 | 1991 | 26 | 0.030 |
Why?
|
| Temperature | 1 | 1991 | 76 | 0.030 |
Why?
|
| DNA | 1 | 1991 | 125 | 0.030 |
Why?
|
| Transfection | 1 | 1991 | 125 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2011 | 132 | 0.020 |
Why?
|
| Pacific Islands | 1 | 2010 | 2 | 0.020 |
Why?
|
| Asia | 1 | 2010 | 9 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 1990 | 23 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 1990 | 4 | 0.020 |
Why?
|
| Vitamin D | 1 | 2010 | 31 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1990 | 8 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1990 | 7 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2010 | 65 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1990 | 14 | 0.020 |
Why?
|
| Apoenzymes | 1 | 1990 | 1 | 0.020 |
Why?
|
| Apoproteins | 1 | 1990 | 1 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1990 | 50 | 0.020 |
Why?
|
| Fractures, Spontaneous | 1 | 2009 | 11 | 0.020 |
Why?
|
| New Mexico | 1 | 2009 | 3 | 0.020 |
Why?
|
| Genes | 1 | 1988 | 8 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1988 | 16 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1990 | 254 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 28 | 0.020 |
Why?
|
| Bone Development | 1 | 2008 | 32 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1987 | 6 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1987 | 23 | 0.020 |
Why?
|
| Adenoviridae | 1 | 1987 | 20 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1987 | 35 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1987 | 78 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 521 | 0.020 |
Why?
|
| Sex Factors | 1 | 2008 | 496 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2008 | 642 | 0.020 |
Why?
|
| Exercise | 1 | 2010 | 468 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1985 | 3 | 0.020 |
Why?
|
| Animals | 2 | 1991 | 4552 | 0.020 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 6 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 4851 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1990 | 4 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 1990 | 5 | 0.010 |
Why?
|
| Operon | 1 | 1990 | 2 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1990 | 9 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1990 | 7 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1990 | 29 | 0.010 |
Why?
|
| Adenovirus Early Proteins | 1 | 1990 | 1 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 1990 | 4 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1990 | 26 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1990 | 52 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1990 | 59 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1990 | 1 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 1990 | 2 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1990 | 80 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1990 | 55 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1990 | 42 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1990 | 96 | 0.010 |
Why?
|
| Cell Line | 1 | 1990 | 298 | 0.010 |
Why?
|
| Genotype | 1 | 1990 | 405 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 11 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1987 | 11 | 0.010 |
Why?
|
| Tubulin | 1 | 1987 | 16 | 0.010 |
Why?
|
| Biological Transport | 1 | 1987 | 43 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1987 | 148 | 0.000 |
Why?
|